Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes M van Noort

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|February 16, 2006
Human glial cell culture models of inflammation in the central nervous systemJohannes M van Noort
Current Opinion in Investigational Drugs (London, England : 2000)|February 1, 2007
Toll-like receptors as targets for inflammation, development and repair in the central nervous systemJohannes M van Noort
Progress in Brain Research|August 8, 2009
Toll-like receptors in the CNS: implications for neurodegeneration and repairJohannes M van Noort, Malika Bsibsi
CNS & Neurological Disorders Drug Targets|November 3, 2016
Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous SystemJohannes M van Noort, Marianna Bugiani, Sandra Amor
CNS & Neurological Disorders Drug Targets|May 16, 2012
Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factorsJohannes M van Noort, David Baker, Sandra Amor
Clinical and Experimental Immunology|July 6, 2023
The pathogenesis of multiple sclerosis: a series of unfortunate eventsJohannes M van Noort, David Baker, Markus Kipp, et al.
Brain Pathology (Zurich, Switzerland)|January 19, 2016
Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS BarriersFabiola Puentes, Andrea Malaspina, Johannes M van Noort, et al.
Journal of Neuropathology and Experimental Neurology|November 15, 2002
Broad expression of Toll-like receptors in the human central nervous systemMalika Bsibsi, Rivka Ravid, Djordje Gveric, et al.
Journal of Neuroscience Research|October 6, 2011
Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formationMalika Bsibsi, Anita Nomden, Johannes M van Noort, et al.
Biochemical Pharmacology|June 11, 2005
Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL miceRichard Verbeek, Eric A F van Tol, Johannes M van Noort
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|February 16, 2006
Human glial cell culture models of inflammation in the central nervous systemJohannes M van Noort
Current Opinion in Investigational Drugs (London, England : 2000)|February 1, 2007
Toll-like receptors as targets for inflammation, development and repair in the central nervous systemJohannes M van Noort
Progress in Brain Research|August 8, 2009
Toll-like receptors in the CNS: implications for neurodegeneration and repairJohannes M van Noort, Malika Bsibsi
CNS & Neurological Disorders Drug Targets|November 3, 2016
Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous SystemJohannes M van Noort, Marianna Bugiani, Sandra Amor
CNS & Neurological Disorders Drug Targets|May 16, 2012
Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factorsJohannes M van Noort, David Baker, Sandra Amor
Clinical and Experimental Immunology|July 6, 2023
The pathogenesis of multiple sclerosis: a series of unfortunate eventsJohannes M van Noort, David Baker, Markus Kipp, et al.
Brain Pathology (Zurich, Switzerland)|January 19, 2016
Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS BarriersFabiola Puentes, Andrea Malaspina, Johannes M van Noort, et al.
Journal of Neuropathology and Experimental Neurology|November 15, 2002
Broad expression of Toll-like receptors in the human central nervous systemMalika Bsibsi, Rivka Ravid, Djordje Gveric, et al.
Journal of Neuroscience Research|October 6, 2011
Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formationMalika Bsibsi, Anita Nomden, Johannes M van Noort, et al.
Biochemical Pharmacology|June 11, 2005
Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL miceRichard Verbeek, Eric A F van Tol, Johannes M van Noort
Pageof 5